SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filing Details

Document Details

Filing Date
May 10, 2010
Document Date
May 10, 2010
Form Description
Registration of up to an additional 20% of securities for any offering registered on a S-3
Filing Group
Registration Statements
Company
Jazz Pharmaceuticals plc
Issuer
JAZZ PHARMACEUTICALS PLC